about
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survivalA new paradigm for primary prevention strategy in people with elevated risk of stroke.Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.Recent trends in lipid management: raising the bar and shifting the goalposts?High persistence of statin use in a Danish population: compliance study 1993-1998.Which interventions offer best value for money in primary prevention of cardiovascular disease?Statin withdrawal: clinical implications and molecular mechanisms.Statin-associated weakness in myasthenia gravis: a case report.Statin-Associated Underactive Bladder.Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease.Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy.Efficacy of a telephone-based medical nutrition program on blood lipid and lipoprotein metabolism: Results of Our Healthy Heart.Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients.
P2860
Q33548525-F4266254-236D-4508-9647-53F8BEE7E34CQ34074955-FA92B689-8AB9-4A07-8A05-AA50B4F5751DQ34289448-3CA2FEC7-32B1-4279-8673-C05BA3A04127Q35072212-1D073C32-C919-4BD4-BDD3-2EBAE1F1B619Q35803620-A76145BF-05B0-401B-8994-F5C496439573Q36109666-4DAAE5FB-23CE-4470-B3FB-9A213969E9F9Q36582678-63DD1704-0416-4C5C-B495-5ACA696599B6Q39490425-3231B338-D73D-427B-B48E-AEE06A6485B8Q40215570-A3843AC4-D176-4D4D-A1A4-E1473A9CED28Q40228551-A844227C-4DAC-43DA-ABCD-37F7B5065A55Q44746157-7371922D-08BF-471B-9404-519FCF6C8EE1Q48091727-6D91E926-6529-4F81-A7A2-D12A5026B61AQ50043145-B49E019A-A526-4F93-B025-7BC18B656EB5
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Discontinuation rates for use of statins are high.
@ast
Discontinuation rates for use of statins are high.
@en
type
label
Discontinuation rates for use of statins are high.
@ast
Discontinuation rates for use of statins are high.
@en
prefLabel
Discontinuation rates for use of statins are high.
@ast
Discontinuation rates for use of statins are high.
@en
P2093
P1433
P1476
Discontinuation rates for use of statins are high.
@en
P2093
P2860
P356
10.1136/BMJ.321.7268.1084
P407
P577
2000-10-01T00:00:00Z